A study of angiogenesis in head and neck cancers and its application to cancer gene therapy
A study of angiogenesis in head and neck cancers and its application to cancer gene therapy
批准号:
12671678
负责人:
TAMURA Shinji
金额:
$1.22万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
将血管内皮生长因子(VEGF)基因转染到头颈癌细胞系中,观察基因诱导对肿瘤生长的影响。结果如下:1. VEGF基因转染头颈部癌细胞系,建立不表达VEGF的上颌骨癌细胞系,命名为OKK-LN。将VEGF基因表达载体转染OKK-LN细胞,建立了能表达VEGF的OKK-LN/pCIneo-VEGF。与对照细胞株OKK-LN/pCIneo相比,该细胞株VEGF表达增强. VEGF转染的细胞移植到裸鼠的肿瘤细胞生长。两种细胞系通过皮下注射到右侧腹部移植到6周的Balb/c nu/nu小鼠。在移植后第35天,VEGF转染组(OKK-LN/pCIneo-VEGF; n = 6)的肿瘤体积显示为对照组(OKK-LN/pCIneo ; n = 8)的约3倍。VEGF转染组与对照组相比平均生存期缩短9天.血管生成抑制因子对肿瘤生长的抑制检测了TNP-470(烟曲霉素类似物)对产生VEGF的肿瘤生长的影响,TNP-470非特异性地抑制由血管生成增殖因子如VEGF和bFGF诱导的血管生成。在移植OKK-LN/pCIneo-VEGF的同时向裸鼠施用TNP-470。在移植后第35天和第42天,TNP-470给药组(n = 5)的肿瘤体积与未给药组(n = 5)相比显著减少至三分之一。TNP-470给药组的生存期明显延长。总之,血管生成对头颈部癌细胞的生长、转移和生存起着重要作用。
英文摘要
Vascular endothelial growth factor (VEGF) gene was transfected to the head and neck cancer cell line and the effect of gene induction on the tumor growth was examined in vitro and in vivo. The results were as follows ;1. VEGF gene transfection to the head and neck cancer cell line.The maxillary cancer cell line expressing no VEGF was established in our department and named as OKK-L N. VEGF gene expressing vector was transfected to OKK-LN cell line, and OKK-LN/pCIneo-VEGF which producing VEGF was established. This ceU line intensively expressed VEGF compared with the control cell line, OKK-LN/pCIneo transfected only pCIneo plasmid.2. Tumor cell growth of the VEGF-transfectd cells transplanted to nude mouse.Both cell lines transplanted to 6 week Balb/c nu/nu mice by subcutaneous injection to right lateral abdomen. Tumor volume of the VEGF-transfected group (OKK-LN/pCIneo-VEGF ; n = 6) showed approximately three times larger than the controlled group (OKK-LN/pCIneo ; n = 8) at Day 35 after the transplantation. The survival of the VEGF-transfected group was shorter by 9 days in average compared to the control group.3. Inhibition of the tumor growth by the angiogenesis suppression factor.The effect of TNP-470, Fumagilin analogue, which nonspecifically inhibits angiogenesis induced by the angiogenesis proliferating factors, such as VEGF and bFGF on the growth of VEGF producing tumor was examined. TNP-470 was simultaneously administered to nude mice at the time of transplantation of OKK-LN/pCIneo-VEGF. Tumor volume of TNP-470 administered group (n = 5) was significantly reduced to one-third compared with non-administered group (n = 5) at Day 35 and Day 42 after the transplantation. And the survival of TNP-470 administered group was significantly prolonged.In conclusion, the angiogenesis plays important roles on cancer cell growth, metastasis and survival in head and neck cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of phase transition of the rare earth oxyfluorides
-
批准号:20K05077
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2020
-
负责人:TAMURA Shinji
-
依托单位:
Development of the divalent cation conducting solid electrolytes
-
批准号:24750202
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$3.0万
-
财政年份:2012
-
负责人:TAMURA Shinji
-
依托单位:
Studies on High-valent Cation Conducting Solid Electrolytes
-
批准号:21750208
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:TAMURA Shinji
-
依托单位:
Evaluation of novel metastasis-related genes and development of an early diagnostic marker in head and neck cancer
-
批准号:21592204
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:TAMURA Shinji
-
依托单位:
A study of risk factors for intractable otitis media and nasopharyngeal transmission of causative pathogen
-
批准号:15591828
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2003
-
负责人:TAMURA Shinji
-
依托单位:
Study on gene therapy for liver regeneration. -Effect of gene transduction of soluble HB-EGF and soluble TGF-β type II receptor on liver regeneration-
-
批准号:13670517
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:2001
-
负责人:TAMURA Shinji
-
依托单位:
Study on the gene therapy of soluble-HB-EGF gene to accelerate liver regeneration.
-
批准号:11670500
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1999
-
负责人:TAMURA Shinji
-
依托单位:
Effect of HB-EGF on liver regeneration in vovo and its application as a therapeutic agent.
-
批准号:09670544
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:TAMURA Shinji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
-
批准号:82372007
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:谢文晖
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
RNA编辑型IGFBP7在肿瘤细胞与肿瘤血管微环境中的调控作用及机制研究
-
批准号:32070790
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:徐小燕
-
依托单位:
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题
-
批准号:81171370
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:朱朝晖
-
依托单位:
探索VASH2转录激活对肝细胞癌血管生成和上皮间质转化的作用及机制
-
批准号:81172267
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:高文涛
-
依托单位:
解析miR-566调控VHL/β-catenin信号通路影响人脑胶质瘤血管新生的分子机制
-
批准号:81101916
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:周旋
-
依托单位:
脂肪组织来源干细胞促进颗粒脂肪游离移植后再血管化机制的实验研究
-
批准号:81171834
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:鲁峰
-
依托单位:
99mTc-3PRGD2 SPECT显像用于评价肺癌抗新生血管药物疗效的动物研究及肺癌诊断临床研究
-
批准号:81171369
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:李方
-
依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
-
批准号:81071183
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王荣福
-
依托单位: